Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care

NCT05254795 is registered in ClinicalTrials.gov with Timothy Mullett as lead sponsor.

NCT NCT05254795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05254795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care
Lead sponsor
Timothy Mullett
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 13, 2022
Completion date
December 22, 2026
Enrollment
659 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer